Haley J Appaneal1,2, Megan K Luther1,2, Tristan T Timbrook1,2, Kerry L LaPlante1,2,3, David M Dosa1,4. 1. Veterans Affairs Medical Center, Providence, RI, USA. 2. University of Rhode Island, Kingston, RI, USA. 3. Warren Alpert Medical School of Brown University, Providence, RI, USA. 4. Brown University School of Public Health, Providence, RI, USA.
Abstract
Background: The Veterans Affairs (VA) is a leader in the implementation and advancement of antibiotic stewardship programs throughout the nation. The Centers for Disease Control and Prevention (CDC) has also led national antibiotic stewardship efforts and has outlined core elements to improve antibiotic use in hospitals, long-term care, and outpatient settings. Many facilities still face challenges to the implementation and maintenance of successful programs, particularly in nonacute care settings. The objective of this study was to identify barriers and facilitators to antibiotic stewardship within the VA medical centers through qualitative interviews with pharmacists. Methods: Eight semi-structured telephone interviews were conducted with pharmacists from 6 VA medical centers within VA New England Healthcare System. Pharmacist respondents were either pharmacy champions (for medical centers with established programs) or pharmacists with responsibilities in making antibiotic recommendations (locations without established programs). All interviews were audio recorded and transcribed verbatim. NVivo 8 was used for data coding and analysis. Results: Pharmacists from all 8 medical centers were contacted for interviews and pharmacists from 6 medical centers agreed to interviews (75% VA New England medical center participation). Three main themes regarding antibiotic stewardship were identified from the interviews with pharmacists. Respondents described the importance of (1) a supportive organizational culture, (2) protected time for antibiotic stewardship, and (3) a cohesive organizational structure in the success of antibiotic stewardship programs. Conclusions: Our findings support the CDC core elements for antibiotic stewardship, in particular the importance of leadership commitment in the creation of a culture that supports antibiotic stewardship and in ensuring staff are given sufficient time for antibiotic stewardship efforts. Although a strong supportive culture has been built, strategies focused on fostering increased protected time for antibiotic stewardship and a cohesive organizational structure may be helpful in advancing and sustaining successful antibiotic stewardship programs that improve patient outcomes.
Background: The Veterans Affairs (VA) is a leader in the implementation and advancement of antibiotic stewardship programs throughout the nation. The Centers for Disease Control and Prevention (CDC) has also led national antibiotic stewardship efforts and has outlined core elements to improve antibiotic use in hospitals, long-term care, and outpatient settings. Many facilities still face challenges to the implementation and maintenance of successful programs, particularly in nonacute care settings. The objective of this study was to identify barriers and facilitators to antibiotic stewardship within the VA medical centers through qualitative interviews with pharmacists. Methods: Eight semi-structured telephone interviews were conducted with pharmacists from 6 VA medical centers within VA New England Healthcare System. Pharmacist respondents were either pharmacy champions (for medical centers with established programs) or pharmacists with responsibilities in making antibiotic recommendations (locations without established programs). All interviews were audio recorded and transcribed verbatim. NVivo 8 was used for data coding and analysis. Results: Pharmacists from all 8 medical centers were contacted for interviews and pharmacists from 6 medical centers agreed to interviews (75% VA New England medical center participation). Three main themes regarding antibiotic stewardship were identified from the interviews with pharmacists. Respondents described the importance of (1) a supportive organizational culture, (2) protected time for antibiotic stewardship, and (3) a cohesive organizational structure in the success of antibiotic stewardship programs. Conclusions: Our findings support the CDC core elements for antibiotic stewardship, in particular the importance of leadership commitment in the creation of a culture that supports antibiotic stewardship and in ensuring staff are given sufficient time for antibiotic stewardship efforts. Although a strong supportive culture has been built, strategies focused on fostering increased protected time for antibiotic stewardship and a cohesive organizational structure may be helpful in advancing and sustaining successful antibiotic stewardship programs that improve patient outcomes.
Authors: Ebbing Lautenbach; Mark G Weiner; Irving Nachamkin; Warren B Bilker; Angela Sheridan; Neil O Fishman Journal: Infect Control Hosp Epidemiol Date: 2006-08-21 Impact factor: 3.254
Authors: Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton Journal: Clin Infect Dis Date: 2006-12-13 Impact factor: 9.079
Authors: Shira Doron; Lauren Nadkarni; Lori Lyn Price; Pharmd Kenneth Lawrence; Lisa E Davidson; Jack Evans; Caren Garber; David R Snydman Journal: Clin Ther Date: 2013-06 Impact factor: 3.393
Authors: Christopher J Graber; Karl Madaras-Kelly; Makoto M Jones; Melinda M Neuhauser; Matthew Bidwell Goetz Journal: Infect Control Hosp Epidemiol Date: 2013-06 Impact factor: 3.254
Authors: Amy L Pakyz; Leticia R Moczygemba; Lynn M VanderWielen; Michael B Edmond; Michael P Stevens; Anton J Kuzel Journal: Am J Infect Control Date: 2014-10 Impact factor: 2.918
Authors: Ann F Chou; Christopher J Graber; Makoto Jones; Yue Zhang; Matthew Bidwell Goetz; Karl Madaras-Kelly; Matthew Samore; Allison Kelly; Peter A Glassman Journal: Infect Control Hosp Epidemiol Date: 2016-02-24 Impact factor: 3.254
Authors: Lawrence A Palinkas; Sarah M Horwitz; Carla A Green; Jennifer P Wisdom; Naihua Duan; Kimberly Hoagwood Journal: Adm Policy Ment Health Date: 2015-09
Authors: Rebecca R Roberts; Bala Hota; Ibrar Ahmad; R Douglas Scott; Susan D Foster; Fauzia Abbasi; Shari Schabowski; Linda M Kampe; Ginevra G Ciavarella; Mark Supino; Jeremy Naples; Ralph Cordell; Stuart B Levy; Robert A Weinstein Journal: Clin Infect Dis Date: 2009-10-15 Impact factor: 9.079
Authors: Gopi Patel; Shirish Huprikar; Stephanie H Factor; Stephen G Jenkins; David P Calfee Journal: Infect Control Hosp Epidemiol Date: 2008-12 Impact factor: 3.254
Authors: Melanie C Goebel; Barbara W Trautner; Yiqun Wang; John N Van; Laura M Dillon; Payal K Patel; Dimitri M Drekonja; Christopher J Graber; Bhavarth S Shukla; Paola Lichtenberger; Christian D Helfrich; Anne Sales; Larissa Grigoryan Journal: Am J Infect Control Date: 2020-05-08 Impact factor: 2.918
Authors: Tamar F Barlam; Ellen Childs; Sarah A Zieminski; Tsega M Meshesha; Kathryn E Jones; Jorie M Butler; Laura J Damschroder; Matthew Bidwell Goetz; Karl Madaras-Kelly; Caitlin M Reardon; Matthew H Samore; Jincheng Shen; Edward Stenehjem; Yue Zhang; Mari-Lynn Drainoni Journal: Open Forum Infect Dis Date: 2020-06-15 Impact factor: 3.835
Authors: Kay Currie; Rebecca Laidlaw; Valerie Ness; Lucyna Gozdzielewska; William Malcom; Jacqueline Sneddon; Ronald Andrew Seaton; Paul Flowers Journal: Antimicrob Resist Infect Control Date: 2020-07-02 Impact factor: 4.887
Authors: Daniel J Livorsi; Kenda R Stewart Steffensmeier; Eli N Perencevich; Matthew Bidwell Goetz; Heather Schacht Reisinger Journal: Infect Control Hosp Epidemiol Date: 2021-05-17 Impact factor: 6.520
Authors: Shana A B Burrowes; Mari-Lynn Drainoni; Maria Tjilos; Jorie M Butler; Laura J Damschroder; Matthew Bidwell Goetz; Karl Madaras-Kelly; Caitlin M Reardon; Matthew H Samore; Jincheng Shen; Edward Stenehjem; Yue Zhang; Tamar F Barlam Journal: Antimicrob Steward Healthc Epidemiol Date: 2021-11-12
Authors: J Keizer; N Beerlage-De Jong; N Al Naiemi; J E W C van Gemert-Pijnen Journal: Antimicrob Resist Infect Control Date: 2020-08-05 Impact factor: 4.887